UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): May 11, 2015

 

Atossa Genetics Inc.

(Exact name of registrant as specified in its charter)

         
         
Delaware   001-35610   26-4753208
         
(State or other jurisdiction of
incorporation) 		  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

     
     

2345 Eastlake Ave. East, Suite 201

Seattle, Washington

  

 

98102

     
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (206) 325-6086

 

Not Applicable
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

  

Item 5.07. Submission of Matters to a Vote of Security Holders

 

On May 11, 2015, the Company held its 2015 Annual Meeting of Stockholders (the “Annual Meeting”). The following items of business were considered and voted upon at the Annual Meeting: (i) election of two Class III directors to serve until the 2018 annual meeting; and (ii) ratification of the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2015.

 

The number of shares of common stock entitled to vote at the Annual Meeting was 27,217,257. The number of shares of common stock present or represented by valid proxy at the annual meeting was 17,777,117. All matters submitted to a binding vote of stockholders at the Annual Meeting were approved. The number of votes cast for and against, and the number of abstentions and broker non-votes with respect to the matters voted upon at the Annual Meeting, are set forth below:

 

(i) Election of two Class III Directors

             
Director Nominee   Votes For     Votes Withheld  
Shu-Chih Chen, Ph.D.     8,565,723       128,496  
H. Lawrence Remmel, Esq.     8,574,312        119,907  

 

There were 8,998,691 broker non-votes regarding this proposal.

 

(ii) Ratification of Auditors

 

 Stockholders ratified the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015. The results of the voting were 17,649,284 votes for, 118,817 votes against, and 9,012 votes abstained. There were 8,998,691 broker non-votes regarding this proposal.

 

 

Item 9.01. Financial Statements and Exhibits  

 

None

   

* * *

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

         
Date: May 14, 2015 Atossa Genetics Inc.
 		  
  By:   /s/ Kyle Guse   
    Kyle Guse  
    Chief Financial Officer, General Counsel and Secretary